期刊文献+

依达拉奉对血管性痴呆大鼠学习记忆及胆碱乙酰转移酶和高亲和力胆碱转运体表达的影响 被引量:4

Effects of edaravone on learning and memory abilities and expression of choline acetyl transferase and high affinity choline transporter in vascular dementia rats
原文传递
导出
摘要 【摘要】目的研究依达拉奉对血管性痴呆(VaD)大鼠学习记忆及胆碱乙酰转移酶(ChaT)和高亲和力胆碱转运体(ChT)的影响。方法30例大鼠随机数字法分为假手术组、模型组、依达拉奉治疗组,将假手术组双侧颈总动脉进行分离,不阻断血流,不注射药物。模型组、依达拉奉治疗组采用双颈总动脉永久结扎法建立大鼠血管性痴呆(VaD)模型。在3组造模后行Morris进行水迷宫测试,同时用免疫组化法检测大鼠海马ChaT及ChT表达。结果Morris进行水迷宫测试结果显示:第1天模型组逃避潜伏期[(92.6±8.1)s]明显大于假手术组[(71.9±5.1)s]和依达拉奉治疗组[(71.2±4.9)s],差异有统计学意义(P〈0.05);第2,3,4天模型组逃避潜伏期[(85.9±9.8)s、(66.2±8.6)s、(68.9±7.4)s)明显大于假手术组[(51.9±4.9)s、(38.3±4.2)s、(21.1±2.9)s]和依达拉奉治疗组[(52.3±3.9)s、(37.5±3.9)s、(20.2±2.4)s],差异有统计学意义(P〈0.01);模型组穿越平台次数[(4.59±0.89)次]明显少于假手术组[(6.79±1.21)次]和依达拉奉治疗组[(7.21±0.89)次],差异有统计学意义(P〈0.05)。3组海马ChaT灰度值比较:模型组(89.05±9.42)明显高于假手术组(67.44±6.36)和依达拉奉治疗组(62.35±4.69),差异有统计学意义(P〈0.05)。3组海马ChT灰度值比较:模型组(145.33±3.79)明显低于假手术组(164.21±2.85)和依达拉奉治疗组(162.45±4.72),差异有统计学意义(P〈0.05)。结论依达拉奉可有效改善大鼠的学习记忆能力,改善大鼠海马ChaT表达,ChT代偿性表达增高受到抑制。 Objective To investigate the effect and mechanism of edaravone on learning and memory abilities and expressing of choline acetyl transferase(ChaT) and high affinity choline transporter(ChT) in vascular dementia (VaD) rats. Methods 30 rats were randomly divided into sham operation group, model group and edaravone treatment group. The sham operation group with bilateral carotid arteries were isolated only, but did not block the blood flow and not inject drugs. VaD model was established by "two-vessel method" in model group and edaravone treatment group. The three groups underwent the Morris water maze test and immunobistochemistry to de- tect the expression of ChaT and ChT in hippocampus. Conclusion The first day, Morris water maze test showed that the model group escape latency ( ( 92.6± 8. 1 ) s) was significantly greater than the sham operation group ( (71.9 ± 5.1 ) s) and edaravone treatment group ( (71.2 ± 4.9) s), the differences were statistically significant (P 〈0.05). ChaT hippocampal gray value in the model group( (89.05 ±9.42) ) was higher than that in sham operation group ( 67.44 ± 6.36) and edaravone treatment group (62.35 ±4.69), the differences were statistically significant(P 〈 0.05 ). ChT hippocampal gray value in the model group( 145.33 ± 3.79) was lower than that in sham operation group( 164.21± 2.85 ) and edaravone treatment group( 162.45± 4.72), the differences were statistically significant (P 〈 0.05 ). Results Edaravone may be effective in improving learning and memory and protecting neurons in rats, and improve the expression of ChaT, but decrease the expression of ChT in hippocamoal.
作者 周广安
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2013年第5期394-396,共3页 Chinese Journal of Behavioral Medicine and Brain Science
关键词 依达拉奉 血管性痴呆 胆碱乙酰转移酶 高亲和力胆碱转运体 Edaravone Vascular dementia Choline acetyl transferase High affinity choline transporter
  • 相关文献

参考文献13

  • 1Chung JM,Chung K. Importance of hyperexcitability of DHG neuronsin neuropathic pain. Pain Pract,2002 ,2 :87-97.
  • 2Kikuchi K ,Takeshige N , Miura N , et al. Beyond free radical scaven-ging: Beneficial effects of e<laravone ( Radicut) in various diseases.Exp Ther Med,2012,3:3-8.
  • 3Ahmad A, Khan MM , Javed H,et al. Edaravone ameliorates oxidativestress associated cholinergic dysfunction and limits apoptotic responsefollowing focal t-erebral ischemia in rat. Mol Cell Biochem ,2012 ,367 :215-225.
  • 4Lee B,Shiml I,Lee H,et al. Rehmaiinia glutinosa ameliorates scopol-amine-induced learning and memory impairment in rals. J MicrobiolBiotechnol,201 1,21 :874-883.
  • 5Brandon EP,Mellott T,Pizzo DP,et al. Choline transporter 1 maintainscholinergic function in choline acetyltransferase haploinsufllt'iency. JNeurosci ,2004,24:5459-5466.
  • 6Hassanzadeh P, Ahmadiani A. Nitric oxide and c-Jun N-terminal ki-nase are involved in the development of dark neurons inducted by in-flammatory pain . Synapse,2006 ,59 : 101-106.
  • 7Kloppenborg RP, van den Berg Et Kappelle IJ, et al. Diabeles andother vascular risk factors for dementia : which faclor matters most?Asystematic review. Eur J Pharmacol ,2008 ,585 :97-108.
  • 8Ohno K .Tsujino A,Brengman JM,et al. Choline acetyl transferase mu-tations cause myasthenic syndrome associated with episodic apnea inhumans. Proc Natl Acad Sci USA ,2001 ,98:2017-2022.
  • 9Tobiume K, Saitoh M, Ichijo HY, et at. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation ofpre-forme<l oligomer. J Cell Physiol,2002,191 :95-104.
  • 10Pradeep H ,Diya JB,Shashikumar S,et al. Oxidative stress - assassinbehind the ischemic stroke. Folia Neuropathol ,2012,50 :219-230.

同被引文献41

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Ott A,Stolk RP,van Harskamp F,et al.Diabetes mellitus and the risk of dementia:The Rotterdam Study[J].Neurology,1999,53(9):1937-1942.
  • 3Ramos-Rodriguez JJ,Ortiz O,Jimenez-Palomares M,et al.Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice[J].Psychoneuroendocrinology,2013,38(11):2462-2475.
  • 4Sonnen JA,Larson EB,Brickell K,et al.Different patterns of cerebral injury in dementia with or without diabetes[J].Arch Neurol,2009,66(3):315-322.
  • 5Marioni RE,Strachan MW,Reynolds RM,et al.Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes:the Edinburgh Type 2 Diabetes Study[J].Diabetes,2010,59(3):710-713.
  • 6Liu JP,Feng L,Zhang MH,et al.Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat[J].J Ethnopharmacol,2013,150 (1):371-381.
  • 7Shi X,Lu XG,Zhan LB,et al.The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat modal of diabetes-associated cognitive decline:a proteomic analysis[J].Diabetologia,2011,54(7):1888-1899.
  • 8Vorhees CV,Williams MT.Morris water maze:procedures for assessing spatial and related forms of learning and memory[J].Nat Protoc,2006,1 (2):848-858.
  • 9Dejgaard A,Gade A,Larsson H,et al.Evidence for diabetic encephalopathy[J].Diabet Med,1991,8(2):162-167.
  • 10Biessels GJ,van der Heide LP,Kamal A,et al.Ageing and diabetes:implications for brain function[J].Eur J Pharmacol,2002,441 (1-2):1-14.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部